Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | PNMT | P11086 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.37 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8539519 | 0.85 | GABRA1 (0.50) | GABRA1GABRB2HTR2AHTR2CHTR2B | |
| SCHEMBL4670802 | 0.83 | GABRA1 (0.47) | GABRA1GABRB2TRPA1PNMTTAAR1 | |
| SCHEMBL114824 | 0.83 | PTGS1 (0.48) | GABRA1GABRB2TRPA1HTR2A | |
| SCHEMBL9117880 | 0.82 | TAAR1 (0.46) | TRPA1HTR2AHTR2CHTR2BPNMT | |
| SCHEMBL1513596 | 0.81 | SIGMAR1 (0.48) | TRPA1TAAR1SIGMAR1 | |
| SCHEMBL1652966 | 0.81 | TRPA1 (0.43) | TRPA1HTR2AHTR2CHTR2BPNMT | |
| SCHEMBL28951517 | 0.81 | PNMT (0.65) | PNMTTAAR1 | |
| SCHEMBL12934220 | 0.81 | SIGMAR1 (0.48) | TRPA1TAAR1SIGMAR1 | |
| SCHEMBL9338131 | 0.80 | TDP1 (0.46) | GABRA1GABRB2TRPA1PNMTTAAR1 | |
| SCHEMBL19119576 | 0.79 | TAAR1 (0.53) | GABRA1GABRB2HTR2ATAAR1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102574757-B | M-or to substituted-phenyl alkanol method is prepared by alkylation | BASF SE (DE) | 2015-12-02 | — | — | CN | disclosed |
| CN-102596870-B | Method for producing m-substituted phenylalkanols by means of isomerization | BASF SE | 2014-11-05 | — | — | CN | disclosed |
| EP-2490993-B1 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2014-06-11 | — | — | EP | disclosed |
| EP-2490992-B1 | PROCESS FOR PREPARING M- OR P-SUBSTITUTED PHENYLALKANOLS BY ALKYLATION | BASF SE (DE) | 2014-01-29 | — | — | EP | disclosed |
| EP-2490993-A2 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2012-08-29 | — | — | EP | disclosed |
| EP-2490992-A1 | PROCESS FOR PREPARING M- OR P-SUBSTITUTED PHENYLALKANOLS BY ALKYLATION | BASF SE (DE) | 2012-08-29 | — | — | EP | disclosed |
| US-20120209031-A1 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| US-20120209030-A1 | PROCESS FOR PREPARING M- OR P-SUBSTITUTED PHENYLALKANOLS BY ALKYLATION | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| CN-102596870-A | Method for producing m-substituted phenylalkanols by means of isomerization | BASF SE | 2012-07-18 | — | — | CN | disclosed |
| CN-102574757-A | Process for preparing m- or p-substituted phenylalkanols by alkylation | BASF SE | 2012-07-11 | — | — | CN | disclosed |
| WO-2011048012-A1 | PROCESS FOR PREPARING M- OR P-SUBSTITUTED PHENYLALKANOLS BY ALKYLATION | BASF SE (DE) | 2011-04-28 | — | — | WO | disclosed |
| WO-2011048068-A2 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | BASF SE (DE) | 2011-04-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120209031-A1 | METHOD FOR PRODUCING M-SUBSTITUTED PHENYLALKANOLS BY MEANS OF ISOMERIZATION | CRAT, CYP2E1, C9 | GABRA1 3075/4885GABRB2 3457/4885TRPA1 105/4885 |
| US-20120209030-A1 | PROCESS FOR PREPARING M- OR P-SUBSTITUTED PHENYLALKANOLS BY ALKYLATION | C9, CYP1A1, TMT1A | GABRA1 2412/4885GABRB2 3289/4885TRPA1 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.